Look Forward – Winter 2022 – Issue 178
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
Search results
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
We are proud to launch our new Young Persons Project, which will play a significant role in providing impactful and timely support for young people with inherited sight loss and mental health challenges, across the UK.
We are nothing without our amazing community. They are the reason we do what we do and are a constant source of inspiration to us.
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
Stem cells are a special type of cell, which under the right conditions can be encouraged to grow into any other type of cell in the body, including retinal cells (rods, cones and retinal pigment epithelial cells).
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Our community are the reason we are able to continue supporting those with inherited sight-loss conditions through research and practical support.
Inherited progressive sight loss is caused by a range of rare genetic conditions. We specialise in those which affect the retina.
The BBC covered a story on Monday 24 May about optogenetics partially restoring the sight of a man living with retinitis pigmentosa in France.
Nurturing a new generation of scientists is a vital investment in the future of retinal disease research, so we are delighted to be funding, in collaboration with the Macular Society, a new PhD studentship at Oxford University, supervised by Professor Robert MacLaren.